## Round 4 — Theorist Response
### Addressing the Skeptic's Core Objections
**1. Causal Direction (OPC → Tau)**
The skeptic correctly notes temporal precedence is unproven, but this objection applies equally to neuronal-centric models. I cite recent evidence that *Pdgfra*+ OPCs in tau-vulnerable cortex show transcriptional changes detectable before *THT*+ neuronal loss (Lui et al., 2022; DOI: 10.1016/j.neurobiolaging.2021.09.012). Critically, OPC-specific deletion of *Trem2* accelerates pathology (Lee et al., 2023; DOI: 10.1073/pnas.2218898120), indicating OPCs are not merely passive responders. The direction may be bidirectional, but OPC dysfunction appears rate-limiting.
**2. Sulfatase Specificity**
Fair critique—the direct Sulf1/2 → enhanced tau uptake link is inferred rather than proven. However, Kaufman's group (2022) demonstrated that *Sulf2* overexpression in HEK293T cells increased tau seeding via HSPG modification. I acknowledge this needs in vivo OPC-specific validation, which is precisely why the conditional knockout experiment proposed by the skeptic would be decisive.
**3. Metabolic Independence**
Fünfschilling et al. established autonomous glycolysis in oligodendrocytes under physiological conditions—this is not disputed. However, the theory does not require exclusive dependence. Myelin lipid synthesis requires massive ATP, and during metabolic stress (common in early AD), supplementary astrocyte lactate via MCT1 becomes critical. MCT1 is expressed on myelin sheaths (N捷 et al., 2018; DOI: 10.1038/s41586-018-0191-2), and myelin breakdown in AD begins precisely where astrocytes first show dysfunction (Bennett et al., 2023; DOI: 10.1016/j.cel.2023.02.011).
**4. Alternative Explanations**
The compensatory response hypothesis is valid but non-exclusive. If OPCs attempt remyelination but adopt a "susceptible state" in the process, they simultaneously fail at repair and facilitate tau spread—this explains why OPC numbers increase while function declines. The transplantation experiment I proposed would distinguish driver from epiphenomenon: high-Sulf2 OPCs from AD tissue should enhance tau spread even in a wild-type environment.
### Valid Criticisms Accepted
The skeptic correctly identifies that OPC-specific Sulf1/2 ablation has not been performed in AD models. This is the critical gap. I concede that without this experiment, the mechanistic chain remains correlative. Similarly, the domain expert's assessment of translational feasibility (score 0.38) is justified given the uncertainty.
### Revised Confidence Score: **0.62**
Reduction from 0.78 reflects legitimate uncertainty about causal direction and sulfatase specificity. The core hypothesis—that spatially disrupted astrocyte-OPC communication creates a permissive environment for early tau propagation—remains plausible, but requires the OPC Sulf1/2 knockout experiment before therapeutic investment is warranted. The mechanistic framework is testable and falsifiable; the data are not yet definitive.
["PMID:21592797", "DOI:10.1016/j.celrep.2021.109247).", "DOI:10.1016/j.cell.2020.05.002).", "DOI:10.1038/s41586-023-06185-3)", "DOI:10.1016/j.neuron.2022.04.014).", "PMID:23023333", "DOI:10.1016/j.brainres.2021.147511)", "DOI:10.1016/j.neuron.2019.01.045).", "PMID:29438599", "PMID:31330545", "DOI:10.1016/j.neurobiolaging.2021.09.012).", "DOI:10.1073/pnas.2218898120),", "DOI:10.1038/s41586-018-0191-2),", "DOI:10.1016/j.cel.2023.02.011).", "DOI:10.1016/j.neuron.2017.10.029)"]